News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Merck & Co., Inc. (JOBS) Starts Generic Arm to Copy Biologic Medicines
December 9, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Merck & Co. will start a new unit to copy biotechnology medicines, increasing the drugmaker's stake in the $94 billion market for treatments based on living cells.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Startups
MORE ON THIS TOPIC
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
March 12, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds
March 12, 2026
·
35 min read
·
BioSpace Editorial Staff
Weight loss
Lilly Flags ‘Concerning’ Impurities in Compounded Tirzepatide
March 12, 2026
·
2 min read
·
Tristan Manalac
C-suite
J&J, AbbVie CEOs See Pay Spike to More Than $30M
March 12, 2026
·
1 min read
·
Tristan Manalac
